| Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics DA Costello, DW Lee, J Drewes, KA Vasquez, K Kisler, U Wiesner, ... Analytical chemistry 84 (20), 8480-8489, 2012 | 49 | 2012 |
| Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC). JK Rotow, DB Costa, CP Paweletz, MM Awad, P Marcoux, D Rangachari, ... Journal of Clinical Oncology 38 (15_suppl), 9507-9507, 2020 | 37 | 2020 |
| Slowing translation between protein domains by increasing affinity between mRNAs and the ribosomal anti-Shine–Dalgarno sequence improves solubility KA Vasquez, TA Hatridge, NC Curtis, LM Contreras ACS synthetic biology 5 (2), 133-145, 2016 | 21 | 2016 |
| Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples JK Khalsa, J Cha, F Utro, A Naeem, I Murali, Y Kuang, K Vasquez, L Li, ... Blood 142 (5), 421-433, 2023 | 7 | 2023 |
| Codon selection affects recruitment of ribosome-associating factors during translation AM Rojano-Nisimura, K Haning, J Janovsky, KA Vasquez, JP Thompson, ... ACS Synthetic Biology 9 (2), 329-342, 2019 | 5 | 2019 |
| BCL-2 G101V mutations develop in one-third of patients on continuous venetoclax Y Kuang, SM Fernandes, R Fardoun, K Vasquez, A Mogili, CP Paweletz, ... Cancer Research 82 (12_Supplement), 3960-3960, 2022 | 1 | 2022 |
| Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL) I Murali, J Cha, I Leshchiner, Y Kuang, K Vasquez, J Khalsa, ... Cancer Research 81 (13_Supplement), 1097-1097, 2021 | | 2021 |
